Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study.
The drugs – called cilostazol and isosorbide mononitrate – are already used to treat other conditions, such as heart disease and angina.
This is the first time they have been tested in the UK for the treatment of stroke or vascular dementia.
A study involving more than 50 stroke patients found that patients tolerated the drugs, with no serious side effects, even when the drugs were given in full dose or in combination with other medicines.
Experts say the findings pave the way for larger studies to check if the treatments can prevent brain damage and reduce risk of stroke and vascular dementia.
Damage to small blood vessels in the brain is responsible for around a quarter of strokes. It is also a common cause of memory problems and dementia.
Around 400,000 people in the UK are affected but there are no specific treatments. Currently the only way to reduce risk of the disease is by controlling blood pressure and cholesterol, stopping smoking and managing symptoms of diabetes.
Promising early signs
A team led by the Universities of Edinburgh and Nottingham recruited 57 patients who had experienced a stroke caused by damaged small blood vessels, known as a lacunar stroke.
Patients took the two medicines either individually or in combination for up to nine weeks, in addition to usual treatments aimed at preventing further strokes.
They completed health questionnaires and had regular blood pressure checks, blood tests and brain scans.
The findings suggest the drugs are safe for use in stroke patients, taken alone or in combination, at least in the short term.
There were also signs that the treatments helped improve blood vessel function in the arms and brain, and may improve thinking skills, but the researchers stress that further studies are needed to test this. A larger study, called LACI-2, is already underway.
The study, published in EClinicalMedicine, was funded primarily by the Alzheimer’s Society, with support from the UK Stroke Association, British Heart Foundation, the European Union, National Institutes of Health Research, and NHS Research Scotland.
We are delighted that the results of this trial show promise for treating a common cause of stroke and the commonest cause of vascular dementia, since currently there are no effective treatments. Further trials are underway.
Professor Joanna Wardlaw Centre for Clinical Brain Sciences
There hasn’t been a new drug for dementia for 15 years, so finding evidence that these cheap existing drugs could prevent dementia after a stroke would be a huge breakthrough. It’s promising to see that these two drugs are safe to use and we’ll be excited to see the results of the next stage of testing in a couple of years, which will show whether these drugs can be an effective treatment.
Dr James PickettHead of Research at Alzheimer’s Society
Learn more: Drugs to prevent stroke and dementia show promise
The Latest on: Stroke and vascular dementia
[google_news title=”” keyword=”stroke and vascular dementia” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stroke and vascular dementia
- The Role of the Neurologic Examination in the Diagnosis and Categorization of Dementiaon June 3, 2023 at 4:59 pm
Frontal gait disorder is seen most commonly with vascular dementia and late in the course ... lateralizing motor and sensory signs residual to stroke, and cortical and subcortical signs ...
- Rosalynn Carter diagnosed with dementia at 95: What to know about the condition in the ‘oldest old’on June 2, 2023 at 4:05 am
Rosalynn Carter, 95, wife of former President Jimmy Carter, has been diagnosed with dementia. Diagnosis and risk factors are very different for people in their 90s, a doctor explains.
- Commonly used heart disease drugs may reduce the risk of post-stroke dementiaon May 31, 2023 at 6:00 am
Two drugs commonly used to treat heart problems could help improve cognitive function, including memory, after a lacunar stroke. Lacunar strokes are associated with a higher risk of cognitive ...
- Stroke-Related Dementiaon May 14, 2023 at 5:01 pm
Cognitive decline related to stroke is usually called vascular dementia or vascular cognitive impairment to distinguish it from other types of dementia. In the United States, it is the second most ...
- Doctor shares two symptoms of vascular dementia that can appear in 'step-wise fashion'on May 13, 2023 at 8:59 pm
Following a stroke, interrupted blood flow to the ... oxygen to the brain is at higher risk of developing vascular dementia. In fact, there are multiple risk factors for vascular dementia ...
- What is the difference between Alzheimer’s and dementia?on May 4, 2023 at 9:00 am
Dementia symptoms specific to vascular dementia include stroke-like symptoms, such as as muscle weakness, movement and thinking problems and mood changes, such as depression. There are several ...
- Vascular Dementiaon May 3, 2023 at 5:00 pm
 Macrovascular complications of diabetes include heart disease and stroke; there also is an association between diabetes and dementia. An extension of the Action to Control Cardiovascular Risk ...
- Signs You Have "Vascular Dementia"on May 26, 2022 at 6:04 am
Vascular dementia is the second most common type of dementia after Alzheimer's disease, and is caused by a lack of blood flow to the brain (such as from a stroke). "About 15% to 20% of dementia ...
- A Patient's Guide to Vascular Dementiaon April 24, 2019 at 8:19 am
In the absence of stroke, she says, "there never is one big, dramatic moment. It's more of a gradual, slow damage to the brain that will eventually cause dementia." Vascular dementia's course is ...
- Poststroke dementia—what's in a name?on February 1, 2010 at 4:00 am
Indeed, such a deficit is a prerequisite for a diagnosis of vascular dementia according to the National Institute of Neurological Disorders and Stroke–Association Internationale pour la ...
via Bing News